The Latest Media and News on Penn Immunotherapy

In the Media

Carl June: The World's 100 Most Influential People

Carl June, MD, has been named one of TIME's 100 most influential people for his pioneering work in the development of CAR T cell therapy at the Abramson Cancer Center.

12-year-old Emily Whitehead, the first patient to receive the therapy, explains why he is so deserving of this honor.

Dr. Carl June working in the lab on developing CAR-T cell therapy 

Joe Biden speaks with Meghan McCain about Penn Medicine's CAR-T cell therapy on The View

On ABC's The View, in an emotional interview with Meghan McCain, former Vice President Joe Biden offers hope to those affected by cancer. He discusses the CAR-T cell therapy created at Penn Medicine, saying "There are breakthroughs that are occurring now. And it can happen tomorrow. At the University of Pennsylvania where I teach now, at the Abramson [Cancer] Center, there is a thing called a CAR-T cell. They had a breakthrough with a new drug for child leukemia, and it’s working. There is hope."

Watch the clip:

In the News

Most Recent News Releases

Parker Institute Is Helping Penn Accelerate Immunotherapy Research

Launch of the Parker Institute for Cancer Immunotherapy, with Carl JunePenn was one of six top medical institutions chosen to form the Parker Institute for Cancer Immunotherapy. It brings together the top minds in cancer to share ideas and findings. The mission is to accelerate breakthrough immune therapies to turn cancer into a curable disease.